Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 486.00 | 582.00 | 0.8351 | 0.5219 | |
SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 457.00 | 582.00 | 0.7852 | 0.3864 | |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1604.00 | 1633.25 | 0.9821 | 0.9643 | |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1405.00 | 1633.25 | 0.8603 | 0.7216 | |
SK-BR-3 | Etoposide | 19.9526 | uM | 4 | 1250.00 | 814.29 | 489.00 | 1633.25 | 0.2994 | -0.3982 |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1571.00 | 1633.25 | 0.9619 | 0.9241 | |
SK-BR-3 | Nilotinib | 0.1 | uM | 4 | 1250.00 | 814.29 | 1478.00 | 1633.25 | 0.9049 | 0.8106 |
SK-BR-3 | PLX-4720 | 0.31623 | uM | 4 | 1250.00 | 814.29 | 1934.00 | 1633.25 | 1.1841 | 1.3666 |
SK-BR-3 | Nilotinib | 10 | uM | 4 | 1250.00 | 814.29 | 1222.00 | 1633.25 | 0.7482 | 0.4982 |
SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 4 | 1250.00 | 814.29 | 788.00 | 1633.25 | 0.4825 | -0.0322 |
SK-BR-3 | NVP-TAE684 | 10 | uM | 4 | 1250.00 | 814.29 | 535.00 | 1633.25 | 0.3276 | -0.3419 |
SK-BR-3 | PLX-4720 | 3.1623 | uM | 4 | 1250.00 | 814.29 | 1634.00 | 1633.25 | 1.0005 | 1.0009 |
SK-BR-3 | PLX-4720 | 1 | uM | 4 | 1250.00 | 814.29 | 1997.00 | 1633.25 | 1.2227 | 1.4434 |
SK-BR-3 | Nilotinib | 19.9526 | uM | 4 | 1250.00 | 814.29 | 1838.00 | 1633.25 | 1.1254 | 1.2496 |
SK-BR-3 | Nilotinib | 1 | uM | 4 | 1250.00 | 814.29 | 1930.00 | 1633.25 | 1.1817 | 1.3618 |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1665.00 | 1633.25 | 1.0194 | 1.0387 | |
SK-BR-3 | NVP-TAE684 | 1 | uM | 4 | 1250.00 | 814.29 | 1494.00 | 1633.25 | 0.9147 | 0.8302 |
SK-BR-3 | Nilotinib | 0.031623 | uM | 4 | 1250.00 | 814.29 | 1516.00 | 1633.25 | 0.9282 | 0.8570 |
SK-BR-3 | PLX-4720 | 0.0033113 | uM | 4 | 1250.00 | 814.29 | 1698.00 | 1633.25 | 1.0396 | 1.0790 |
SK-BR-3 | Etoposide | 3.1623 | uM | 4 | 1250.00 | 814.29 | 732.00 | 1633.25 | 0.4482 | -0.1007 |
SK-BR-3 | Etoposide | 0.31623 | uM | 4 | 1250.00 | 814.29 | 1030.00 | 1633.25 | 0.6306 | 0.2637 |
SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 4 | 1250.00 | 814.29 | 1597.00 | 1633.25 | 0.9778 | 0.9558 |
SK-BR-3 | Etoposide | 0.1 | uM | 4 | 1250.00 | 814.29 | 1359.00 | 1633.25 | 0.8321 | 0.6654 |
SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 4 | 1250.00 | 814.29 | 1310.00 | 1633.25 | 0.8021 | 0.6056 |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1553.00 | 1633.25 | 0.9509 | 0.9021 |